Also trades as: 9939.HK (HKSE) · $vol 0M
KNTPF OTC
Kintor Pharmaceutical Limited
1W: +0.0%
1M: +0.7%
3M: -29.4%
YTD: +11.8%
1Y: -6.7%
3Y: -75.8%
5Y: -80.4%
$0.24
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$515M
-40.7% ▼
5Y CAGR: +292.4%
Total Liabilities
$221M
-46.2% ▼
5Y CAGR: +313.1%
Shareholders Equity
$294M
-35.8% ▼
5Y CAGR: +280.3%
Cash & Investments
$149M
-67.4% ▼
5Y CAGR: +276.4%
Total Debt
$133M
-47.6% ▼
5Y CAGR: +15.7%
Net Debt
-$14M
+92.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1M | $930K | $865K | $445M | $147M |
| Short-Term Investments | $328K | $127K | $12K | $10M | $1M |
| Cash & ST Investments | $1M | $1M | $877K | $455M | $149M |
| Net Receivables | $555K | $1.1B | $874M | $9M | $2M |
| Inventory | $0 | $351M | $604M | $0 | $2M |
| Other Current Assets | $1.4B | -$1.5B | $8M | $425K | $14M |
| Total Current Assets | $1.4B | $2M | $1.5B | $473M | $172M |
| Property, Plant & Equip. | $187M | $262K | $282M | $191M | $166M |
| Goodwill & Intangibles | $210K | $236K | $236K | $149M | $157M |
| Long-Term Investments | $0 | $0 | $18K | $8M | $17M |
| Other Non-Current Assets | $244M | $0 | $265M | $26M | $4M |
| Total Non-Current Assets | $431M | $498K | $547M | $397M | $343M |
| Total Assets | $1.9B | $2.1B | $2.1B | $869M | $515M |
| — Liabilities — | |||||
| Accounts Payable | $29M | $45M | $78M | $68M | $39M |
| Short-Term Debt | $84M | $7M | $99M | $114M | $112M |
| Deferred Revenue | $0 | -$9M | -$103M | $0 | $0 |
| Other Current Liabilities | $361K | $9M | $83M | $0 | $0 |
| Total Current Liabilities | $169M | $220M | $318M | $225M | $167M |
| Long-Term Debt | $135M | $148M | $178M | $133M | $20M |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $174M | $193M | $242M | $186M | $54M |
| Total Liabilities | $344M | $413M | $560M | $411M | $221M |
| — Equity — | |||||
| Common Stock | $261 | $273K | $315K | $315K | $315K |
| Retained Earnings | -$927K | -$1.8B | -$2.7B | -$3.8B | -$3.9B |
| Accumulated OCI | $2M | $65M | $115M | $61M | $24M |
| Total Stockholders Equity | $2M | $1.7B | $1.5B | $458M | $294M |
| Total Liabilities & Equity | $1.9B | $2.1B | $2.1B | $869M | $515M |
| — Key Metrics — | |||||
| Total Debt | $222M | $160M | $286M | $254M | $133M |
| Net Debt | $221M | $159M | $286M | -$192M | -$14M |
| Total Investments | $328K | $127K | $30K | $18M | $18M |